Suppr超能文献

糖尿病作为墨西哥人 SARS-CoV-2 检测阳性的一个风险因素:一项倾向评分匹配研究。

Diabetes mellitus as a risk factor for SARS-CoV-2 test positivity in Mexico: A propensity score matched study.

机构信息

Diabetes Unit, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA.

Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Mexico.

出版信息

Diabetes Res Clin Pract. 2021 Aug;178:108953. doi: 10.1016/j.diabres.2021.108953. Epub 2021 Jul 21.

Abstract

AIMS

We sought to investigate whether individuals with diabetes have a higher likelihood of testing positive for SARS-CoV-2, as a proxy for infection risk, than individuals without diabetes.

METHODS

We conducted a cross-sectional study of publicly available data among a Mexican population, totaling 2,314,022 adults ≥ 18 years who underwent SARS-CoV-2 testing between March 1 and December 20, 2020. We used 1:1 nearest neighborhood propensity score matching by diabetes status to account for confounding among those with and without diabetes.

RESULTS

In the overall study population, 1,057,779 (45.7%) individuals tested positive for SARS-CoV-2 and 270,486 (11.7%) self-reported diabetes. After propensity score matching, patient characteristics were well-balanced, with 150,487 patients in the diabetes group (mean [SD] age 55.9 [12.7] years; 51.3% women) and 150,487 patients in the no diabetes group (55.5 [13.3] years; 50.3% women). The strictest matching algorithm (1:1 nearest neighbor) showed that compared to individuals without diabetes, having diabetes was associated with 9.0% higher odds of having a positive SARS-CoV-2 test (OR 1.09 [95% CI: 1.08-1.10]).

CONCLUSIONS

Presence of diabetes was associated with higher odds of testing positive for SARS-CoV-2, which could have important implications for risk mitigation efforts for people with diabetes at risk of SARS-CoV-2 infection.

摘要

目的

我们旨在研究糖尿病患者与非糖尿病患者相比,其 SARS-CoV-2 检测呈阳性的可能性是否更高,以作为感染风险的替代指标。

方法

我们对墨西哥人群中公开可用的数据进行了横断面研究,共纳入 2314022 名年龄≥18 岁的成年人,他们在 2020 年 3 月 1 日至 12 月 20 日期间接受了 SARS-CoV-2 检测。我们使用按糖尿病状态进行的 1:1 最近邻居倾向评分匹配来控制糖尿病患者和非糖尿病患者之间的混杂因素。

结果

在整个研究人群中,有 1057779 名(45.7%)个体 SARS-CoV-2 检测呈阳性,270486 名(11.7%)自我报告患有糖尿病。在倾向评分匹配后,患者特征得到了很好的平衡,糖尿病组有 150487 名患者(平均[标准差]年龄 55.9[12.7]岁;51.3%为女性),无糖尿病组有 150487 名患者(55.5[13.3]岁;50.3%为女性)。最严格的匹配算法(1:1 最近邻居)显示,与无糖尿病患者相比,患有糖尿病与 SARS-CoV-2 检测呈阳性的几率增加 9.0%相关(比值比 1.09[95%置信区间:1.08-1.10])。

结论

糖尿病的存在与 SARS-CoV-2 检测呈阳性的几率增加相关,这对于有感染 SARS-CoV-2 风险的糖尿病患者的风险缓解努力可能具有重要意义。

相似文献

10
Association of COVID-19 Infection With Incident Diabetes.COVID-19 感染与新发糖尿病的关联。
JAMA Netw Open. 2023 Apr 3;6(4):e238866. doi: 10.1001/jamanetworkopen.2023.8866.

引用本文的文献

1
Avocado Oil: Recent Advances in Its Anti-diabetic Potential.鳄梨油:其抗糖尿病潜力的最新进展
Curr Med Sci. 2025 Feb;45(1):11-24. doi: 10.1007/s11596-025-00010-w. Epub 2025 Feb 25.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验